PTC THERAPEUTICS, INC. (NASDAQ:PTCT) filed a Form 8-K with the Securities and Exchange Commission on February 12, 2026, disclosing a material event.
PTC THERAPEUTICS, INC.'s stock currently trades at $70.70 with a market capitalization of $6.1B. The Healthcare company's stock moved following the disclosure.


